Hospital-acquired infections (HAIs) are a global burden affecting millions of patients each year, causing significant increases in patient morbidity and mortality. Crucial for better patient outcome but also to reduce healthcare costs is early pathogen identification for swift selection of appropriate antimicrobial therapy.
Direct Multiplex Imaging (DMI) is the combination of a novel DNA-based multiplex hybridization technology with automatic imaging. DMI enables fast, specific and reproducible identification of multiple pathogenic microorganisms directly from samples, providing evidence for timely decisions and a targeted antibiotic therapy.
MetaSystems products are used in many countries worldwide. Depending on the regulations of the respective country or region, some products may not be used for clinical diagnostic use. In Europe MetaSystems products are CE labelled in-vitro diagnostics (IVD) devices. In the USA all MetaSystems products except the Ikaros karyotyping systems are intended to be used for research or inspection only.